Who Holds Autolus Therapeutics plc (AUTL)? 84 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 84 holders, $212 million in total.
Largest holders
The 84 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| MAK CAPITAL ONE LLC | 33,621,487 | $54 million | +0% | 13F |
| Blackstone Inc. | 20,485,611 | $33 million | +0% | 13F |
| Syncona Portfolio Ltd | 16,640,720 | $27 million | +0% | 13F |
| ARMISTICE CAPITAL, LLC | 15,000,000 | $24 million | -5% | 13F |
| Tetragon Partners GP Ltd | 9,500,000 | $15 million | +0% | 13F |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 7,833,282 | $13 million | -17% | 13F |
| Frazier Life Sciences Management, L.P. | 4,447,910 | $7 million | +0% | 13F |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 3,361,156 | $5 million | +0% | 13F |
| Laurion Capital Management LP | 3,316,626 | $5 million | +0% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 1,984,700 | $3 million | -14% | 13F |
| BANK OF AMERICA CORP /DE/ | 1,605,092 | $3 million | -13% | 13F |
| BlackRock, Inc. | 1,603,458 | $3 million | +8% | 13F |
| UBS Group AG | 1,516,991 | $2 million | +16% | 13F |
| MORGAN STANLEY | 1,260,832 | $2 million | +34% | 13F |
| MILLENNIUM MANAGEMENT LLC | 1,224,818 | $2 million | +498% | 13F |
| Cetera Investment Advisers | 1,157,324 | $2 million | +3% | 13F |
| Balyasny Asset Management L.P. | 972,748 | $2 million | +0% | 13F |
| JPMORGAN CHASE & CO | 913,239 | $2 million | -2% | 13F |
| Alphabet Inc. | 698,262 | $1 million | +0% | 13F |
| CITADEL ADVISORS LLC | 695,890 | $1 million | +51% | 13F |
| Hennion & Walsh Asset Management, Inc. | 451,403 | $722,245 | +3% | 13F |
| Privium Fund Management B.V. | 363,430 | $581,488 | +0% | 13F |
| JANE STREET GROUP, LLC | 299,862 | $479,779 | +22% | 13F |
| EDENTREE ASSET MANAGEMENT Ltd | 300,000 | $477,000 | +0% | 13F |
| XTX Topco Ltd | 287,456 | $459,930 | +410% | 13F |
| WELLS FARGO & COMPANY/MN | 212,592 | $340,147 | +2% | 13F |
| Erste Asset Management GmbH | 195,000 | $321,750 | +0% | 13F |
| DAFNA Capital Management LLC | 179,316 | $286,906 | +0% | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 177,232 | $283,572 | -56% | 13F |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 150,000 | $240,000 | +0% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 123,934 | $198,294 | +12% | 13F |
| Clearstead Advisors, LLC | 121,107 | $193,772 | +0% | 13F |
| Quadrature Capital Ltd | 114,883 | $183,813 | +110% | 13F |
| GOLDMAN SACHS GROUP INC | 113,556 | $181,690 | -2% | 13F |
| Leonteq Securities AG | 100,000 | $160,000 | +0% | 13F |
| MARSHALL WACE, LLP | 94,654 | $151,445 | +255% | 13F |
| STATE STREET CORP | 84,409 | $135,054 | +1% | 13F |
| Point72 Asset Management, L.P. | 71,227 | $113,963 | -83% | 13F |
| Invesco Ltd. | 66,447 | $106,315 | +25% | 13F |
| SmartHarvest Portfolios, LLC | 63,602 | $101,763 | +7% | 13F |
| HighPoint Advisor Group LLC | 57,000 | $91,200 | -15% | 13F |
| LPL Financial LLC | 42,625 | $68,200 | +13% | 13F |
| RHUMBLINE ADVISERS | 38,764 | $62,017 | +11% | 13F |
| R Squared Ltd | 36,426 | $58,282 | -8% | 13F |
| China Universal Asset Management Co., Ltd. | 31,925 | $51,080 | -10% | 13F |
| Rathbones Group PLC | 28,050 | $44,880 | +0% | 13F |
| OSAIC HOLDINGS, INC. | 27,724 | $44,360 | +13% | 13F |
| Waverly Advisors, LLC | 26,870 | $42,992 | +0% | 13F |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 25,192 | $40,307 | -45% | 13F |
| Delaney Dennis R | 24,000 | $38,400 | +0% | 13F |
| Independent Advisor Alliance | 22,342 | $35,748 | +0% | 13F |
| QUANTUM FINANCIAL PARTNERS LLC | 18,795 | $30,072 | New | 13F |
| QRG CAPITAL MANAGEMENT, INC. | 18,325 | $29,320 | +68% | 13F |
| Marex Group Ltd | 17,857 | $28,571 | -97% | 13F |
| Aigen Investment Management, LP | 17,837 | $28,539 | New | 13F |
| StoneX Group Inc. | 16,965 | $27,318 | New | 13F |
| Vanguard Personalized Indexing Management, LLC | 16,960 | $27,136 | +20% | 13F |
| Caitong International Asset Management Co., Ltd | 16,201 | $25,922 | -69% | 13F |
| Lido Advisors, LLC | 15,509 | $24,814 | New | 13F |
| GAMMA Investing LLC | 15,499 | $24,798 | +116% | 13F |
| BLAIR WILLIAM & CO/IL | 15,000 | $24,000 | New | 13F |
| SIH Partners, LLLP | 14,887 | $23,819 | +0% | 13F |
| Apollon Wealth Management, LLC | 14,019 | $22,430 | +0% | 13F |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 14,000 | $22,400 | -7% | 13F |
| Claro Advisors Inc. | 12,500 | $20,000 | +0% | 13F |
| BARCLAYS PLC | 11,939 | $19,102 | +48% | 13F |
| WEALTH EFFECTS LLC | 10,000 | $16,000 | +0% | 13F |
| Mirae Asset Global Investments Co., Ltd. | 8,971 | $14,354 | -14% | 13F |
| Tower Research Capital LLC (TRC) | 7,533 | $12,053 | -63% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 6,882 | $11,011 | +50% | 13F |
| CITIGROUP INC | 4,718 | $7,549 | -16% | 13F |
| GF FUND MANAGEMENT CO. LTD. | 4,154 | $6,646 | -7% | 13F |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 3,700 | $5,920 | New | 13F |
| Integrated Wealth Concepts LLC | 3,316 | $5,306 | New | 13F |
| Quarry LP | 1,581 | $2,530 | New | 13F |
| CALDWELL SUTTER CAPITAL, INC. | 500 | $800 | +0% | 13F |
| Byrne Asset Management LLC | 100 | $160 | +0% | 13F |
| HRT FINANCIAL LP | 89,363 | $142 | New | 13F |
| SBI Securities Co., Ltd. | 54 | $86 | -2% | 13F |
| Allworth Financial LP | 50 | $80 | +0% | 13F |
| ACADIAN ASSET MANAGEMENT LLC | 28,129 | $45 | +2% | 13F |
| Virtu Financial LLC | 23,557 | $38 | New | 13F |
| TrinityBridge Ltd | 6,300 | $10 | +0% | 13F |
| HUNTINGTON NATIONAL BANK | 1 | $2 | +0% | 13F |
Questions and answers
- How many institutions hold Autolus Therapeutics plc?
- 84 managers reported Autolus Therapeutics plc on Form 13F for the quarter ended 30 June 2026, against 84 the quarter before.
- Who is the largest institutional holder of Autolus Therapeutics plc?
- MAK CAPITAL ONE LLC, with 33,621,487 shares worth $54 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Autolus Therapeutics plc in Q2 2026?
- 10 managers reported a new position and 10 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Autolus Therapeutics plc, Q2 2026", https://app.tamarly.ai/holders/autolus-therapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.